Interestingly enough, in their transgenic model of CD200R−/− mice, Goulding et al. showed that CD200R loss prevents influenza-induced secondary bacterial superinfection while promoting NK cells [40], which further strengthen the therapeutic potential of MIM as preventive care against respiratory infectious diseases. This evidence concerns the gene CD200R1 and influenza.